Skip to main content

Advertisement

Fig. 3 | Health and Quality of Life Outcomes

Fig. 3

From: Health-related quality of life in thrombocytopenic patients with chronic hepatitis C with or without cirrhosis in the ENABLE-1 and ENABLE-2 studies

Fig. 3

Odds ratios of changes in CLDQ-HCV scores at various time points. Odds of (a) a drop in CLDQ-HCV scores greater than the MIC at the end of AVT treatment and (b) a return to baseline levels in overall CLDQ-HCV score. AVT, antiviral therapy; CD, cumulative dose; CLDQ-HCV, Chronic Liver Disease Questionnaire–Hepatitis C Virus version; EVR, early virologic response; IFN, interferon; MELD, Model for End-Stage Liver Disease; MIC, minimally important change; SVR, sustained virologic response

Back to article page